Instil Bio (FRA:5GT0) OCF Yield %: -69.14 (As of Jul. 27, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:5GT0 Instil Bio Inc FRA:5GT0
31 GF Score
Price €6.10
! 3 Warning Signs
View Full Analysis

What is Instil Bio OCF Yield %?

Instil Bio FRA:5GT0 31 OCF Yield % is -69.14 as of Jul. 27, 2026. GuruFocus rates FRA:5GT0 with a GF Score™ of 31/100. The stock has 3 warning signs investors should review. Among 1,408 Biotechnology companies, Instil Bio ranks worse than 86.36% on this metric.

OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

As of today, Instil Bio's Trailing 12-Month Cash Flow from Operations is €-29.02 Mil, and Market Cap is €42.92 Mil. Therefore, Instil Bio's OCF Yield % for today is -69.14%.

The historical rank and industry rank for Instil Bio's OCF Yield % or its related term are showing as below:

FRA:5GT0' s OCF Yield % Range Over the Past 10 Years
Min: -172.38   Med: -63.56   Max: -0.88
Current: -69.14


During the past 7 years, the highest OCF Yield % of Instil Bio was -0.88%. The lowest was -172.38%. And the median was -63.56%.

FRA:5GT0's OCF Yield % is ranked worse than
86.36% of 1408 companies
in the Biotechnology industry
Industry Median: -8.695 vs FRA:5GT0: -69.14

Instil Bio's OCF Margin % for the quarter that ended in Mar. 2026 was %.


Instil Bio OCF Yield % Explanation

Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Instil Bio OCF Yield % Related Terms


Instil Bio OCF Yield % Historical Data

* Premium members only.

The historical data trend for Instil Bio's OCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Instil Bio OCF Yield % Chart

Instil Bio Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Yield %
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 -51.81

Instil Bio Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
OCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 -40.05 -10.11

FRA:5GT0 vs AURX, MCRB, DWTX: OCF Yield % Comparison

For the Biotechnology subindustry, Instil Bio's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Instil Bio OCF Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Instil Bio's OCF Yield % distribution charts can be found below:

* The bar in red indicates where Instil Bio's OCF Yield % falls into.


FRA:5GT0
31GF Score
Instil Bio Inc FRA:5GT0
OCF Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Instil Bio OCF Yield % Calculation

OCF Yield % is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

Instil Bio's OCF Yield % for the fiscal year that ended in Dec. 2025 is calculated as

OCF Yield %=Cash Flow from Operations / Market Cap
=-31.273 / 60.3598
=-51.81%

Instil Bio's annualized OCF Yield % for the quarter that ended in Mar. 2026 is calculated as

OCF Yield %=Cash Flow from Operations * Annualized Factor / Market Cap
=-1.157 * 4 / 45.7785
=-10.11%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Yield % →
What does a OCF Yield % of -69.14 mean?
Instil Bio (FRA:5GT0) has a OCF Yield % of -69.14 as of Jul. 27, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Instil Bio and its competitors. According to the industry distribution chart, Instil Bio ranks #1216 out of 1408 companies in the Biotechnology industry, placing it in the top 86.4%.
Is Instil Bio's OCF Yield % too high?
Instil Bio's current OCF Yield % is -69.14. Based on the distribution chart, Instil Bio ranks #1216 out of 1408 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Instil Bio has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does Instil Bio's OCF Yield % compare to AURX and MCRB?
According to the Biotechnology industry distribution chart, Instil Bio ranks #1216 out of 1408 companies for OCF Yield %. This places Instil Bio in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Biotechnology company?
A good OCF Yield % depends on the Biotechnology industry context. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Instil Bio and its competitors. Instil Bio's current OCF Yield % is -69.14. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Instil Bio stock overvalued right now?
Instil Bio (FRA:5GT0) has a current OCF Yield % of -69.14. The current OCF Yield % is -69.14. Instil Bio's overall GF Score™ is 31/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Instil Bio (FRA:5GT0), the current OCF Yield % is -69.14 as of Jul. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Instil Bio Business Description

Other Exchanges TIL:USA
Address 3963 Maple Avenue, Suite 350, Dallas, TX, USA, 75219
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.
31GF Score

Get the complete analysis for FRA:5GT0

OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€6.10
Price